Advanced search
Publication Cover
Breast Cancer: Targets and Therapy Volume 16, 2024 - Issue
Submit an article Journal homepage
112
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer

Yuying Zhou1 Department of Oncology and Hematology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, Zhejiang, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Wu Xue2 Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of ChinaView further author information
,
Xinyu Meng2 Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of ChinaView further author information
,
Adheesh Bhandari2 Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China;3 Department of Surgery, Breast and Thyroid Unit, Primera Hospital, Kathmandu, NepalORCID Iconhttps://orcid.org/0000-0002-0406-2685View further author information
ORCID Icon,
Hanqian Zeng4 Department of Surgical Oncology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang Province, People’s Republic of ChinaView further author information
,
Rajan KC5 Central Department of Zoology, Tribhuvan University, Kirtipur, Kathmandu, NepalView further author information
,
Suzita Hirachan6 Department of General Surgery, Breast and Thyroid Unit, Tribhuvan University, Teaching Hospital, Kathmandu, NepalView further author information
&
Erjie Xia2 Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 71-89 | Received 21 Nov 2023, Accepted 14 Feb 2024, Published online: 05 Mar 2024

References

  • Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. Ca a Cancer J Clin. 2021;71(1):7–33.
  • Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca a Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Polyak K. Breast cancer: origins and evolution. J Clin Invest. 2007;117(11):3155–3163. doi:10.1172/JCI33295
  • Bhandari A, Zheng C, Sindan N, et al. COPB2 is up-regulated in breast cancer and plays a vital role in the metastasis via N-cadherin and Vimentin. J Cell Mol Med. 2019;23(8):5235–5245. doi:10.1111/jcmm.14398
  • Guan Y, Bhandari A, Xia E, et al. lncRNA FOXD3-AS1 is associated with clinical progression and regulates cell migration and invasion in breast cancer. Cell Biochem Funct. 2019;37(4):239–244. doi:10.1002/cbf.3393
  • Howlader N, Altekruse SF, Li CI, et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J National Cancer Inst. 2014;106(5). doi:10.1093/jnci/dju055
  • Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321(3):288–300. doi:10.1001/jama.2018.19323
  • Noone AM, Howlader N, Krapcho M, et al. SEER cancer statistics review, 1975–2015, National Cancer Institute, Bethesda, MD. Based on November 2017 SEER data submission, posted to the SEER web site; 2018. Available from: https://seer.cancer.gov/csr/1975_2015/. Accessed August 11, 2021.
  • Kaushik AK, Shojaie A, Panzitt K, et al. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nat Commun. 2016;7(1):11612. doi:10.1038/ncomms11612
  • Zhang S, Zhang H, Li H, et al. Potential role of glucosamine-phosphate N-acetyltransferase 1 in the development of lung adenocarcinoma. Aging. 2021;13(5):7430–7453. doi:10.18632/aging.202604
  • Zheng X, Li Y, Ma C, et al. Independent prognostic potential of GNPNAT1 in lung adenocarcinoma. Biomed Res Int. 2020;2020:8851437. doi:10.1155/2020/8851437
  • Wang Z, Embaye KS, Yang Q, et al. Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes. Can Cell Inter. 2021;21(1):219. doi:10.1186/s12935-021-01915-x
  • Liu W, Jiang K, Wang J, et al. Upregulation of GNPNAT1 predicts poor prognosis and correlates with immune infiltration in lung adenocarcinoma. Front Mol Biosci. 2021;8:605754. doi:10.3389/fmolb.2021.605754
  • Yu X, Zhang X, Zhang Y. Identification of a 5-gene metabolic signature for predicting prognosis based on an integrated analysis of tumor microenvironment in lung adenocarcinoma. J Oncol. 2020;2020:5310793. doi:10.1155/2020/5310793
  • Zhang J, Zhang J, Yuan C, et al. Establishment of the prognostic index reflecting tumor immune microenvironment of lung adenocarcinoma based on metabolism-related genes. J Cancer. 2020;11(24):7101–7115. doi:10.7150/jca.49266
  • Zhu P, Gu S, Huang H, et al. Upregulation of glucosamine-phosphate N-acetyltransferase 1 is a promising diagnostic and predictive indicator for poor survival in patients with lung adenocarcinoma. Oncol Lett. 2021;21(6):488. doi:10.3892/ol.2021.12750
  • Shi Q, Li Y, Li S, et al. LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer. Nat Commun. 2020;11(1):5513. doi:10.1038/s41467-020-19349-w
  • Oren Y, Tsabar M, Cuoco MS, et al. Cycling cancer persister cells arise from lineages with distinct programs. Nature. 2021;596(7873):576–582. doi:10.1038/s41586-021-03796-6
  • Hoy AJ, Nagarajan SR, Butler LM. Tumour fatty acid metabolism in the context of therapy resistance and obesity. Nat Rev Cancer. 2021;21(12):753–766.
  • Savas P, Virassamy B, Ye C, et al. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nature Med. 2018;24(7):986–993. doi:10.1038/s41591-018-0078-7
  • Byrne A, Savas P, Sant S, et al. Tissue-resident memory T cells in breast cancer control and immunotherapy responses. Nat Rev Clin Oncol. 2020;17(6):341–348. doi:10.1038/s41571-020-0333-y
  • Stanton SE, Disis ML. Clinical significance of tumor-infiltrating lymphocytes in breast cancer. J Immuno Ther Cancer. 2016;4(1):59. doi:10.1186/s40425-016-0165-6
  • Zhang Z, Zhang Y, Xia S, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579(7799):415–420. doi:10.1038/s41586-020-2071-9
  • Yuan R, Zhang Y, Wang Y, et al. GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer. Front Immunol. 2023;14:1152678. doi:10.3389/fimmu.2023.1152678

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.